Efficacy and safety of new anti-epileptic drug revealed by phase III study

New findings from a phase 3 clinical trial suggest an additional therapeutic option may be coming down the pike. Researchers performed a randomized, double-blind, placebo-controlled study in the United States and Europe on the efficacy and safety of the drug brivaracetam, an analog of the commonly used AED levetiracetam, in adults with poorly controlled partial onset seizures.